Qiu et al. reported that EBF1 is significantly overexpressed in triple-negative breast cancer (TNBC) and suppresses the co-activator function of histone acetyltransferase p300 by forming a complex with p300 and HIF1α [27]. This evidence concerns the gene EP300 and triple-negative breast carcinoma.